Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, aleglitazar and its metabolite M6 were evaluated for safety in non-clinical settings, revealing organ-targeting effects common to PPAR agonists but no significant tumor increase in rat carcinogenicity studies, supporting progression to Phase 3 clinical trials.

In this case report, the use of oral Bhringraj Vati, coconut hair oil, and neutral shampoo treatment improved hair fall and overall hair condition in a 28-year-old female patient, showing safety and effectiveness against symptoms like scalp itching and hair thinning.

This study observed that adults with thinning hair who ingested a patented botanical-based supplement experienced significant increases in hair shaft diameter and reductions in hair breakage over 180 days, suggesting improved hair strength and length across various demographic groups.

In this report from Dr Batra's Homeopathy Clinic, a 21-year-old female with Female Pattern Hair Loss experienced notable improvement in hair fall, scalp health, and overall well-being after receiving individualized homeopathic treatment over twelve months, despite limited success with previous conventional therapies.

This study reported that participants applying topical human platelet exosome extract serum experienced significant improvements in hair volume, density, scalp coverage, and overall hair health compared to a placebo, and no adverse effects were observed.

In a 3-month study, over 90% of healthy women experiencing self-perceived hair thinning reported that the nutritional supplement DEEPLY ROOTED improved their hair growth, volume, and quality, without significant adverse effects.

This study assessed the psychosocial impact and disease burden of alopecia areata among adolescents and adults in Australia, finding substantial impacts on physical, emotional, and quality of life overall, with greater disease burden in patients experiencing more extensive hair loss.

In this study, Diabliss Hair Water was found to improve hair growth rate, density, and quality while reducing hair fall in healthy adults experiencing hair thinning concerns.

This source does not report research results; it promotes a Hair Boost Serum marketed for improving hair health in UK conditions.

This article promotes the use of Hair Boost Serum in the UK, describing its benefits for enhancing hair growth, reducing hair fall, and improving hair and scalp health through nourishing ingredients, but does not report any specific research findings.

In this case study, the combination of microneedling and intradermal therapy was observed to effectively stimulate hair growth and improve hair density in a menopausal woman with androgenetic alopecia, resulting in enhanced self-esteem and cosmetic satisfaction.

In this observational study, patients in India using Sebamed® anti-hair-loss shampoo for 16 weeks experienced improvements in hair growth, thickness, hair fall count, and density, with healthcare professionals reporting good to excellent tolerability in 96.4% of cases.

This study in adult male albino rats reported that human umbilical cord blood-derived mesenchymal stem cells were more effective than minoxidil in promoting hair growth for androgenic alopecia, observing superior outcomes in hair follicle metrics.

This study found that intradermal injections of cultured autologous dermal sheath cup cells for androgenetic alopecia showed hair loss stabilization at 24 months without serious adverse effects and a sustained response in some participants.

This article discusses the challenges and lack of progress in improving burn care outcomes for patients aged 65 and older, highlighting the urgent need for tailored treatment protocols and better understanding of their long-term care needs.

In this observational study, most patients with multiple sclerosis on teriflunomide who experienced hair thinning reported it as mild or moderate and largely recovered while continuing treatment.

This study found that androgenic alopecia is the strongest predictor of coronary artery disease in young men from Western India, followed by premature graying and obesity.

This study found that 27% of women with polycystic ovary syndrome reported perceived scalp hair thinning, which was associated with factors like advancing age, subjective hirsutism, disturbed sleep, smoking, abnormal glucose tolerance, and meal skipping.

In this analysis, the authors examine how hairdressing techniques like thinning and micro-graduation can correct women's hairlines by softening optical contours and enhancing visual symmetry, emphasizing the relevance of individual factors such as morphology and stylistic expectations in selecting these non-medical approaches.

This abstract discusses the potential of platelet-rich plasma as a promising solution for hair loss and thinning, highlighting its efficiency, safety, and reproducibility compared to traditional treatments like hair grafts.

The abstract discusses the potential of platelet-rich plasma as a new, efficient, safe, and reproducible solution for hair loss and thinning, highlighting advancements in growth factors and stem cell technology. However, this summary does not report specific findings or results.

This investigation found that certain supplements, particularly whey protein isolate, growth hormones, and anabolic steroids, can negatively impact hair loss by affecting biochemical pathways.

5% minoxidil foam helps women with thinning hair.

This study found that an oral marine protein supplement significantly increased hair growth and reduced hair shedding in women with temporary thinning hair over 90 days compared to a placebo.

This study found that a marine complex supplement significantly reduced hair shedding and increased hair growth in men with thinning hair over 180 days.

This article reviews the biological causes and treatment options for facial aging but reports no new clinical findings.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

This study found that androgenetic alopecia is the leading cause of hair loss in adolescents and may indicate endocrine disorders, emphasizing the need for accurate diagnosis.

This review discusses the impact of oncological therapy on hair loss, highlighting that while most alopecia is reversible, it can be permanent depending on treatment type and factors.

This study found that skin disorders were more common among schoolchildren in Kashmir Valley, North India, with eczema and acne vulgaris being the most prevalent conditions.